2800 Campus Drive, #50
Plymouth , MN 55441
U.S.
Related Content
September 20, 2012 — Boston Scientific Corp. has signed a definitive agreement to acquire BridgePoint Medical Inc., a ...
September 20, 2012
Feature | Mark Michael, M.D., and Jeffrey A. Breall, M.D., Ph.D.
Management of coronary chronic total occlusion (CTO) is individualized depending on the severity of symptoms, ischemia ...
March 19, 2012
January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology ...
January 25, 2012
January 20, 2012 - BridgePoint Medical Inc. this week signed an agreement with Covidien to exclusively license the ...
January 20, 2012
August 5, 2011 — BridgePoint Medical Inc., a Minnesota-based medical device company, has enrolled its first patient in ...
August 05, 2011
May 19, 2011 - BridgePoint Medical Inc. has announced that they have received clearance of an expanded indication for ...
May 19, 2011
October 5, 2010 – A U.S. clinical study evaluating the CrossBoss and Stingray catheters in treating chronically occluded ...
October 05, 2010
November 24, 2009 – European CE mark clearance was granted this week for BridgePoint Medical’s coronary and peripheral ...
November 24, 2009
March 13, 2009 - BridgePoint Medical Inc. completed the first human clinical case in the U.S. using its CrossBoss CTO ...
March 13, 2009